Tag: Quality

Study: Adjuvant nivolumab reduces risk of death, lung cancer recurrence

Editor's Note An analysis of two phase-III trials showed adjuvant administration of nivolumab (Opdivo) plus chemotherapy reduces the risk of recurrence or death in patients with resectable non-small cell lung cancer (NSCLC) by 40% compared to neoadjuvant nivolumab plus chemotherapy alone, Medpage Today reported September 9. "With the caveat that…

Read More

By: Matt Danford
September 18, 2024
Share

Analysis: Hospital safety, quality measures surpass pre-pandemic levels

Editor's Note An American Hospital Association (AHA) analysis of data from Vizient reveals that hospital performance levels in the first quarter of this year was on par with performance prior to the COVID-19 pandemic, despite patients exhibiting more significant healthcare needs. Released this month, the report analyzes data from 2019…

Read More

By: Matt Danford
September 17, 2024
Share

FDA designates Class 1 recall for infusion system components

Editor's Note The US Food and Drug Administration (FDA) has designated Fresenius Kabi’s recall of certain Ivenix infusion system components as Class 1, the most severe category indicating risk of serious injury or death. According to the agency’s September 16 announcement, the recalled items consist of a certain lot (3010538)…

Read More

By: Matt Danford
September 16, 2024
Share

WHO, Joint Commission mark World Patient Safety Day

Editor's Note In partnership with the World Health Organization (WHO), The Joint Commission and The Joint Commission and Joint Commission International (JCI) invite organizations, health professionals, patients, and their advocates to recognize World Patient Safety Day Tuesday, September 17. This year’s theme is “improving diagnosis for patient safety.” This theme…

Read More

By: Matt Danford
September 16, 2024
Share

NYU Langone surgeons complete first fully robotic lung transplant in US

Editor's Note Surgeons at NYU Langone Health used a da Vinci X robotic system throughout an entire lung transplant procedure for the first time in the US and the third time in the world, DotMed reported September 11. Led by Dr. Stephanie Chang, the surgery offered a fast, minimally invasive…

Read More

By: Matt Danford
September 13, 2024
Share

Study: C-sections more likely for black women

Editor's Note Research shows black women are 25% more likely to undergo cesarean sections (C-sections) than white women, even when presenting similar medical histories, The New York Times reported September 10. The article focuses on a study analyzing nearly one million births across 68 New Jersey hospitals. Conducted between 2008…

Read More

By: Matt Danford
September 12, 2024
Share

Congressional hearing exposes US organ transplant system failures

Editor's Note Lost organs, widespread fraud, and live donors mistakenly presumed deceased are among the alarming issues with the US organ transplant system detailed in a recent Congressional hearing, MedPage Today reported September 11. As part of the House Energy & Commerce Oversight and Investigations Subcommittee, the hearing aimed to…

Read More

By: Matt Danford
September 12, 2024
Share

Trump-Harris debate highlights contrast on abortion, Affordable Care Act

Editor's Note The healthcare portion of the September 10 debate between former President Donald Trump and Vice President Kamala Harris focused on two issues: abortion and the Affordable Care Act (ACA).  Becker’s Hospital Review published key takeaways from the exchange September 11. According to the article, Trump reiterated that the…

Read More

By: Matt Danford
September 11, 2024
Share

Study: bariatric surgery beats medication for hypertension control

Editor's Note Findings to be presented at the American Heart Association's Hypertension Scientific Sessions 2024 suggest bariatric surgery may offer more effective long-term control of high blood pressure for people with obesity compared to medications and lifestyle changes, according to a September 5 report in News Medical. According to the…

Read More

By: Matt Danford
September 6, 2024
Share

Flexibility for clinicians in managing RAS inhibitors in noncardiac surgery

Editor's Note A new study, the Stop-or-Not Trial, has found no significant difference in outcomes for patients undergoing noncardiac surgery who either continued or discontinued their renin-angiotensin system (RAS) inhibitor therapy, MedPage Today August 31 reports. The randomized clinical trial, which included over 2,200 patients, reported the rate of death…

Read More

By: Tarsilla Moura
September 3, 2024
Share

Join our community

Learn More
Video Spotlight
Live chat by BoldChat